Refolding Record:
Protein | |
---|---|
Protein Name | Interleukin-2 |
Abbreviated Name | IL-2 |
SCOP Family | Short Chain Cytokines |
Structure Notes | |
Organism | Human |
UniProt Accession | P60568 |
SCOP Unique ID | n/a |
Structure Solved | |
Class | Alpha |
Molecularity | Monomer |
Construct | |
---|---|
Full Length | y |
Domain | n/a |
Chimera | n/a |
Variants | n/a |
Chain Length | 153 |
Molecular Weight | 17627.7 |
Pi | 7.66 |
Molecular Weight | 17627.7 |
Disulphides | 1 |
Full Sequence |
MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT
|
Notes | n/a |
Expression | |
---|---|
Report | Castellanos-Serra LR, Hardy E, Ubieta R, Vispo NS, Fernandez C, Besada V, Falcon V, Gonzalez M, Santos A, Perez G, Silva A, Herrera L. (1995) FEBS Letters, 378, 171-176 |
Project Aim | Folding |
Fusion | None |
Protein Expression and Production | Protein recombinantly expressed as and refolded from inclusion bodies. |
Expression Host | Escherichia coli |
Expression Strain | W3110 |
Expression Temp | 37.0 |
Expression Time | 12 h |
Expression Vector | pBR322 |
Expression Protocol | Plasmid construction and cell culture The prototrophic E. coli K12 strain W3110 (F-) was transformed according to the method of Hanahan [10] with plasmid plSL-31. This is a vector derived from plasmid pBR322, coding for the N-terminal sequence of interleukin-2 (residues 1 to 22) in which lysine residues 8 and 9 in the IL-2 sequence have been replaced by alanine and glutamine, respectively, followed by a pentapeptide, a lysine residue and the proin-isulin (PI) sequence (Fig. 1). The expression was regulated by the trp promoter. The recombinant strain was grown overnight in Luria Ber- tani medium in the presence of tryptophan (100 #g/ml). Then, 500 ml of culture were inoculated into 5 1 fermentation medium, containing 1% M9 salts, 2% casein hydrolysate, 0.4% glucose, 1% tryptone and 50 #g/ml ampicillin and grown under aeration at 37°C. After 12 h, the cells were harvested and kept at -70°C until use. |
Method of Induction | Tryptophan-rich induction solution |
Cell Density at Induction | OD n/a = n/a |
Cell Disruption Method | Sonication |
Lytic Agent | None |
Pre-Refolding Purification | Ion-exchange chromatography |
Solubility | insoluble |
Refolding | |
---|---|
Refolding Method | Dilution |
Wash Buffer | Standard buffer ( 20 mM Tris-HCl pH 8.0, I mM EDTA, 0.1 rnM phenylmethanesulfonyl fluoride) |
Solubilization Buffer | 12 ml of the standard buffer supplemented with 8 M urea (pH 8.9) |
Refolding Buffer | 50 mM glycine, 1 mM EDTA, pH 10.5, B-mercaptoethanol |
Pre-Refolding Purification | Ion-exchange chromatography |
Tag Cleaved | no tag |
Refolding pH | 10.5 |
Refolding Temperature | 4.0 |
Protein Concentration | n/a |
Refolding Time | 2-24 h |
Redox Agent | Beta-mercaptoethanol |
Redox Agent Concentration | n/a |
Refolding Protocol | 2.2. Isolation and purification of IL2-PI All procedures were done at 0-4°C. Centrifugations were done at 3,000 rpm for 20 rain. Twenty grams of harvested cells were homoge- nated in 100 ml of the standard buffer (20 mM Tris-HCl pH 8.0, I mM EDTA, 0.1 rnM phenylmethanesulfonyl fluoride), supplemented with I M urea and 1% Triton X-100 and disrupted by sonic oscillation (3 cycles, 3 min each). After centrifugation, the sediment was resuspended,agitated and centrifuged successively in 25 ml of the standard buffer supplemented with 4 M urea and 2% Triton X-100, and then twice in 25 ml of the standard buffer. The sediment was solubilized with 12 ml of the standard buffer supplemented with 8 M urea (pH 8.9), stirred for 30 min and centrifuged, The supernatant was diluted with the same buffer to a final concentration of about 3 mg/ml. Cysteine groups were converted into their S-sulfonates by oxidative sulfitolysis, accomplished by the addition of sodium sulfite and sodium tetrathionate (20 eq. sulfite/10eq, tetrathionate/1 eq.cysteine). After 6 h, the reaction was stopped by dilution with water to a final urea concentration of 2 M, and by acidification at pH 4.0 with 2 N HCI. The IL2-PI S-hexasulfon-ate was collected as an abundant white precipitate, which was washed twice with 0.01% HC1 and kept at -20°C or alternatively, it was immediately purified by anion exchange chromatography on a Q-Sepharose Fast Flow column (Pharmacia, Sweden). The column was equilibrated in the loading buffer (8 M urea, 20 mM Tris, 0.2 M NaC1, pH 8.9), the fusion protein hexasulfonate was dissolved and loaded at a protein concentration of about 3 mg/ml and the column was eluted with an increasing NaCI gradient. IL2-PI S-hexasulfonate eluted at about 0.6 M NaC1 and then precipitated by dilution of urea to a final concentration of 2 M after acidification at pH 4.0. 2.3. Folding of the fusion protein and its enzymatic conversion into insulin IL2-PI S-hexasulfonate was dissolved in the folding buffer (50 mM glycine, 1 mM EDTA, pH 10.5) and the solution was degassed. In order to exchange the sulfonate groups and to induce disulfide bond formation, B-mercaptoethanol was added (1.5 eq. per eq. of S-sulfonate) [1]. Folding was performed at protein concentrations varying from 25 pg/ml to 1 mg/ml, at 4°C for varied times from 2 h to 24 h. To stop the reaction, the pH was adjusted to 4.0. Folding products were isolated by reversed phase HPLC, lyophilized, dissolved in 200 mM Tris, pH 9.0, to a protein concentration of 1 mg/ml and digested with trypsin (E/S: 1:600, w/w) or trypsin plus carboxypeptidase B (E/S: 1:600) at 37°C for 5 h. In order to confirm the structure of the main product, the peak corresponding to human insulin as well as a human insulin standard were cleaved with GIu-C endoproteinase at 25°C for 5 h (E/S: 1:20, w/w; in 0.2 M Tris, pH 8.0) and the digestion products were isolated by reversed phase HPLC and analyzed by fast atom bombardment mass spectrometry (FAB-MS). |
Refolding Assay | Unspecified |
Refolding Chaperones | None |
Refolding Additives | None |
Additives Concentration | n/a |
Refolding Yield | n/a |
Purity | n/a |
Notes | n/a |